Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EndoVia Medical was a medical technology company focused on developing robotic-assisted systems for minimally invasive surgery. The company's primary product, the Lap-Proteus, was a computer-assisted robotic system designed to enhance a surgeon's control and precision during laparoscopic procedures. By utilizing a master-slave architecture, the system allowed surgeons to manipulate standard surgical instruments with greater dexterity. EndoVia Medical was acquired by Hansen Medical in 2005 to expand its capabilities in the surgical robotics market. The technology eventually became part of the broader robotic surgery ecosystem through subsequent acquisitions by Auris Health and Johnson & Johnson.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EndoVia Medical.